Forgot your password?

Forgot your username?

database > company
Jan Medical
Medical Devices & Tech
67 E. Evelyn Avenue Suite 6
Mountain View, CA 94041 United States of America
phone:(408) 230-6396
fax:
Symbol Private
Founded 2003
Employees 5
www.janmedical.com
Research Sector Medical Devices & Tech
Summary Description
Stroke and TBI triage and continuous monitoring of patients non- invasively without radiation or other energy inputs.
Management
Paul Lovoi, President and CEO; Founder of Xoft, Tagent, Candescent, Silicon ALPS, InTA
Keywords
stroke, traumatic brain injury, TBI, monitoring, concussion, triage, non-invasive, non significant risk

Comment | Printable Version | Modify profile |
Updated: Apr. 05, 2011

Description
Jan Medical is a medical devices company that has developed a cutting edge diagnostic technology for stroke and brain trauma analysis. The company's technology uses passive sonar techniques with powerful signal processing, to detect, identify and locate each type of stroke and brain trauma using a simple headset and portable laptop based console. The system allows continuous monitoring but can make the first diagnosis within minutes, a speed at which no current imaging technology works at. The system can detect both hemorrhagic and ischemic strokes as well as AVMs, aneurysms and concussions among other conditions, many of which are undetectable with standard imaging technology.
Products / Services
A portable console comprising a laptop computer with an integrated signal processing component along with a lightweight disposable headset.
Technology / Differentiation
No imaging technology today provides the speed of the Jan Medical system, typically less than 5 minutes total without any energy input to the patient. The system can detect both hemorrhagic and ischemic strokes as well as AVMs, aneurysms and concussions among other conditions, many of which are undetectable with standard imaging technology. No current imaging technology can provide continuous monitoring; Jan Medical's system can be left in place for hours or days to monitor critical NCCU patient parameters.
Market / Customers
Neuro Critical Care Unit (NCCU) monitoring for vasospasms Emergency Department detection of ischemia for stroke triage Sports medicine detection of concussion and aiding return to play decisions Military far forward triage of TBI
Competitors / Substitutes / Alternatives
CTA, MRA, and 3D US all contribute to diagnosis in stroke andTBI but CTA and MRA are not portable and are not fast. Standard CT and MRI provide no concussion detection and CT provides less than 15% ischemia confirmation within the 4.5 hour tPA (extended) therapeutic window.
Strategy
The Jan Medical strategy is to enter the stroke market in detecting vasospasm in SAH patients. This is very low hanging opportunity with no gold standard. Then move into the larger market of detecting ischemia within the tPA window. CT has a very low detection rate of 15%. With subsequence verification of hemorrhagic stroke at >90% sensitivity replacement of CT for stroke triage.
Funding
Jan Medical has received angel funding to date and is seeking its first institutional round. Jan Medical requires $3.1M to FDA filing and an additional $2.9M to market launch.
Status
A 40 patient Phase I prospective trial at Johns Hopkins completed to develop stroke classification A 31 player Phase I prospective football concussion trial to develop concussion classification System hardware developed through beta design with signal processing software still in development